Lipid changes in obese patients receiving sibutramine

被引：0
|
作者：
Lean, MEJ
Wickens, M
机构：
[1] Knoll Pharm, Nottingham, England
[2] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3728
引用
收藏
页码：793 / 794
页数：2
相关论文
共 50 条
  • [31] Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study
    Hanotin, C
    Thomas, F
    Jones, SP
    Leutenegger, E
    Drouin, P
    INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (01) : 32 - 38
  • [32] Absence of cardiac valve dysfunction among obese patients treated with sibutramine
    Bach, DS
    Rissanen, AM
    Pekkarinen, TA
    Armstrong, WF
    CIRCULATION, 1998, 98 (17) : 645 - 645
  • [33] Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry
    Sarac, F.
    Pehlivan, M.
    Celebi, G.
    Saygili, F.
    Yilmaz, C.
    Kabalak, I.
    ADVANCES IN THERAPY, 2006, 23 (06) : 1016 - 1029
  • [34] Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women
    Sari, Ramazan
    Eray, Esin
    Ozdem, Sabahat
    Akbas, Halide
    Coban, Erkan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (03) : 179 - 184
  • [35] Meta-analysis of blood pressure in obese patients treated with sibutramine for weight loss shows mean changes are small
    Astrup, A
    Wickens, M
    OBESITY RESEARCH, 2000, 8 : 83S - 83S
  • [36] The local experience of Sibutramine in obese teenagers
    Gupta, N.
    Abu-Assi, R.
    Couper, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A258 - A258
  • [37] Use of sibutramine in obese Hispanic adolescents
    Violante-Ortíz, R
    Del-Rio-Navarro, BE
    Lara-Esqueda, A
    Pérez, P
    Fanghänel, G
    Madero, A
    Berber, A
    ADVANCES IN THERAPY, 2005, 22 (06) : 642 - 649
  • [38] Use of sibutramine in obese hispanic adolescents
    Rafael Violante-Ortíz
    Blanca Estela Del-Rio-Navarro
    Agustín Lara-Esqueda
    Pedro Pérez
    Guillermo Fanghänel
    Agustín Madero
    Arturo Berber
    Advances in Therapy, 2005, 22 : 642 - 649
  • [39] The use of metformin after one-year sibutramine treatment prevents weight gain and improves glucose and lipid metabolism in obese patients
    Ucar, E
    Sabuncu, T
    Yasar, O
    Kilic, F
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S150 - S150
  • [40] Predictor of response to sibutramine therapy in obese non-diabetic and diabetic patients
    Finer, N
    Ryan, D
    Santoro, D
    Pirner, M
    De Rosendo, J
    Renz, C
    OBESITY RESEARCH, 2003, 11 : A111 - A111
12345